|
|
|
|
|
by 9q
3427 days ago
|
|
I can understand it for drug trials. If men are more "homogeneous" and don't create additional parameters with which you have to consider, then for trialing it would make sense. Race wouldn't really play a part here I don't think unless a medicine happened to effect a race differently (e.g. African people often have sickle-cell anemia, so you do have to consider race sometimes as well). But the user above actually said something differently, in that people are treated differently. Like I said, doctors are trained to treat everybody regardless of race/ gender. Clinical trials based on variables of participants, and the general treatment of individuals is completely different. |
|